Results 201 to 210 of about 13,480 (279)
Peptide‐to‐Small Molecule Paradigm: Peptidomimetics have evolved from simple mimicry toward drug‐like scaffolds supported by increasing clinical successes. This Perspective highlights the geometric design principles—linear repetition, convergent fusion, and cyclization—defining the next‐generation peptidomimetic architectures capable of targeting ...
Jesang Lee +5 more
wiley +2 more sources
How It Started...How It Is Going: From All-Polymer Batteries to Living Fibers-A Journey through Biobased Innovation. [PDF]
Nyström G.
europepmc +1 more source
The cobalt(II) bis(trifluoroacetylcamphorate) scaffold exhibits versatile coordination chemistry with solvent‐driven ligand exchange and geometrical rearrangements, associated with unique chiroptical properties. Microcrystalline suspension of [Co(tfc)2(CH3CN)2] revealed the largest VCD dissymmetry factor ever reported (g ≈ 0.2 at 1600 cm−1), arising ...
Gianmarco Papi +4 more
wiley +2 more sources
From Pathology to Materials Science and Engineering: Harnessing the Amyloid State for Biotechnological Applications. [PDF]
Fallot LB +5 more
europepmc +1 more source
Dehydroamino acids (DHAA) are atypical electrophilic sites that lead to crosslinked proteins in Alzheimer's disease (AD) brains. No catalyst for their formation has been known in humans. We report that metal oxides catalyze β‐elimination of phosphoserine and phosphothreonine in model peptides at pH 7.5°C and 37°C, yielding DHAAs.
Samuel W. Markovich +3 more
wiley +2 more sources
The cytoplasmic protein YedX is a potent inhibitor of CsgA amyloid assembly in E. coli. [PDF]
Gurnani B, Jain N.
europepmc +1 more source
Reply to “CSF Amyloid‐β Risk Stratification in CAA: A Missing Link for Anti‐Amyloid Therapy Safety”
Annals of Neurology, EarlyView.
Philipp Arndt, Stefanie Schreiber
wiley +1 more source
The Many Facets of Metal-Binding Peptides. [PDF]
Mathieu E, Hureau C.
europepmc +1 more source

